Evidence map›Paper›PMID 35713376›Full record

ArticleInorganic chemistry2022

Elucidation of Structure-Activity Relationships in Indolobenzazepine-Derived Ligands and Their Copper(II) Complexes: the Role of Key Structural Components and Insight into the Mechanism of Action.

Irina Kuznetcova, Felix Bacher, Samah Mutasim Alfadul, Max Jing Rui Tham, Wee Han Ang, Maria V Babak, Peter Rapta, Vladimir B Arion

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Inorganic chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Indolo[2,3-Dalton transactions (Cambridge, England : 2003) · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 5 countries.

Irina KuznetcovaInstitute of Inorganic Chemistry of the University of Vienna, Währinger Strasse 42, A-1090 Vienna, Austria.ORCID 0000-0002-7425-3700
Felix BacherInstitute of Inorganic Chemistry of the University of Vienna, Währinger Strasse 42, A-1090 Vienna, Austria.
Samah Mutasim AlfadulDrug Discovery Lab, Department of Chemistry, City University of Hong Kong, Kowloon, Hong Kong SAR 999077, China.
Max Jing Rui ThamDepartment of Chemistry, National University of Singapore, 4 Science Drive 2, Singapore 117544, Singapore.
Wee Han AngDepartment of Chemistry, National University of Singapore, 4 Science Drive 2, Singapore 117544, Singapore.
Maria V BabakDrug Discovery Lab, Department of Chemistry, City University of Hong Kong, Kowloon, Hong Kong SAR 999077, China.ORCID 0000-0002-2009-7837
Peter RaptaInstitute of Physical Chemistry and Chemical Physics, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, SK-81237 Bratislava, Slovak Republic.
Vladimir B ArionInstitute of Inorganic Chemistry of the University of Vienna, Währinger Strasse 42, A-1090 Vienna, Austria.ORCID 0000-0002-1895-6460
University of Vienna · ATCity University of Hong Kong · HKNational University of Singapore · SGSlovak University of Technology in Bratislava · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indolo[3,2-

Indexed as

Antineoplastic AgentsCoordination ComplexesBenzazepinesCell Line, TumorCopperCrystallography, X-RayLigandsStructure-Activity RelationshipAntineoplastic AgentsBenzazepinesCoordination ComplexesCopperLigands

Identifiers

PMID35713376
PMCPMC9490829
OpenAlexW4283065902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.